{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:29:53Z","timestamp":1755800993997,"version":"3.44.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Microscopic polyangiitis (MPA) is a subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a small-vessel vasculitis that can cause organ-threatening complications. Hypertrophic pachymeningitis is a rare, central nervous system manifestation of AAV rarely involving the spine. We herein report a patient with myeloperoxidase-ANCA-positive MPA presenting with progressive cognitive decline and gait disturbance associated with communicating hydrocephalus secondary to spinal hypertrophic pachymeningitis. The patient responded well to high-dose prednisolone and rituximab and showed significant clinical and radiological improvement without surgery. The present case not only demonstrated that spinal hypertrophic pachymeningitis in AAV can cause reversible dementia associated with communicating hydrocephalus but also highlighted the potential of timely immunosuppressive therapy to induce remission.<\/jats:p>","DOI":"10.1093\/mrcr\/rxaf051","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T12:52:26Z","timestamp":1754139146000},"source":"Crossref","is-referenced-by-count":0,"title":["Reversible dementia associated with communicating hydrocephalus secondary to spinal hypertrophic pachymeningitis in ANCA-associated vasculitis"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3516-8607","authenticated-orcid":false,"given":"Yuki","family":"Terashima","sequence":"first","affiliation":[{"name":"Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center , Fuchu, Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1931-5614","authenticated-orcid":false,"given":"Yoshitaka","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center , Fuchu, Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-443X","authenticated-orcid":false,"given":"Naoto","family":"Yokogawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center , Fuchu, Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"2025082009015166000_ref1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2025082009015166000_ref2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/rheumatology\/keae293","article-title":"Distinct features of ANCA-associated hypertrophic pachymeningitis compared with other etiologies: findings from a study of 74 patients","volume":"64","author":"Mart\u00edn-Nares","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2025082009015166000_ref3","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fneur.2018.01166","article-title":"Central nervous system involvement in ANCA-associated vasculitis: what neurologists need to know","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Neurol"},{"key":"2025082009015166000_ref4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rdc.2017.06.006","article-title":"Central nervous system disease in antineutrophil cytoplasmic antibodies-associated vasculitis","volume":"43","author":"Graf","year":"2017","journal-title":"Rheum Dis Clin N Am"},{"key":"2025082009015166000_ref5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-510X(02)00015-1","article-title":"Frequency and patterns of subclinical cognitive impairment in patients with ANCA-associated small vessel vasculitides","volume":"195","author":"Mattioli","year":"2002","journal-title":"J Neurol Sci"},{"key":"2025082009015166000_ref6","first-page":"1470","article-title":"Communicating hydrocephalus secondary to diffuse meningeal spread of Wegener's granulomatosis: case report and literature review","volume":"43","author":"Scarrow","year":"1998","journal-title":"Neurosurgery"},{"key":"2025082009015166000_ref7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cyto.2017.08.013","article-title":"Increased BAFF and APRIL levels in the cerebrospinal fluid of patients with anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis","volume":"99","author":"Shimojima","year":"2017","journal-title":"Cytokine"},{"key":"2025082009015166000_ref8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/brain\/awt314","article-title":"Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody","volume":"137","author":"Yokoseki","year":"2014","journal-title":"Brain"},{"key":"2025082009015166000_ref9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025082009015166000_ref10","doi-asserted-by":"crossref","first-page":"e213420","DOI":"10.1212\/WNL.0000000000213420","article-title":"Long-term clinical landscapes of spinal hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"104","author":"Nakajima","year":"2025","journal-title":"Neurology"},{"key":"2025082009015166000_ref11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.41983","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis","volume":"74","author":"Suppiah","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025082009015166000_ref12","doi-asserted-by":"crossref","first-page":"e2053","DOI":"10.1097\/MD.0000000000002053","article-title":"ANCA-associated systemic vasculitis presenting with hypertrophic spinal pachymeningitis: A report of 2 cases and review of literature","volume":"94","author":"Li","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025082009015166000_ref13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/neurolint16050083","article-title":"Froin\u2019s syndrome: a comprehensive review of the literature and the addition of two new cases","volume":"16","author":"Jacobs","year":"2024","journal-title":"Neurol Int"},{"key":"2025082009015166000_ref14","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s10067-020-04971-2","article-title":"Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis","volume":"39","author":"Ikeda","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025082009015166000_ref15","first-page":"873","article-title":"A case of hypertrophic spinal pachymeningitis associated with MPO-ANCA","volume":"42","author":"Yakushiji","year":"2002","journal-title":"Rinsho Shinkeigaku"},{"key":"2025082009015166000_ref16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41586-023-06993-7","article-title":"Identification of direct connections between the dura and the brain","volume":"627","author":"Smyth","year":"2024","journal-title":"Nature"},{"key":"2025082009015166000_ref17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00234-003-0989-x","article-title":"Is there a correlation between operative results and change in ventricular volume after shunt placement? A study of 60 cases of idiopathic normal-pressure hydrocephalus","volume":"45","author":"Meier","year":"2003","journal-title":"Neuroradiology"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxaf051\/63924197\/rxaf051.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf051\/63924197\/rxaf051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf051\/63924197\/rxaf051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:02:55Z","timestamp":1755694975000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxaf051\/8221423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxaf051","relation":{},"ISSN":["2472-5625"],"issn-type":[{"type":"electronic","value":"2472-5625"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rxaf051"}}